Univariate analysis of contributors to day +365 CD8+ Tem counts
| Possible contributors to the day 365 CD8 Tem count . | P value . |
|---|---|
| CMV reactivation (Y/N) | .009 |
| Sex (M/F) | .24 |
| Moderate/severe cGVHD (Y/N) | .82 |
| Grade II-IV aGVHD to day +100 (Y/N) | .87 |
| Relapse (Y/N) | .92 |
| Posttransplant immunosuppression + abatacept (Y/N) | .87 |
| Non-CMV infections (Y/N) | .43 |
| Recipient age | .89 |
| Donor age | .1 |
| 8/8 vs 7/8 HLA match | .19 |
| Possible contributors to the day 365 CD8 Tem count . | P value . |
|---|---|
| CMV reactivation (Y/N) | .009 |
| Sex (M/F) | .24 |
| Moderate/severe cGVHD (Y/N) | .82 |
| Grade II-IV aGVHD to day +100 (Y/N) | .87 |
| Relapse (Y/N) | .92 |
| Posttransplant immunosuppression + abatacept (Y/N) | .87 |
| Non-CMV infections (Y/N) | .43 |
| Recipient age | .89 |
| Donor age | .1 |
| 8/8 vs 7/8 HLA match | .19 |